TELA Bio, Inc.·4

Feb 25, 5:08 PM ET

Murphy Peter C. 4

4 · TELA Bio, Inc. · Filed Feb 25, 2022

Insider Transaction Report

Form 4
Period: 2022-02-23
Murphy Peter C.
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2022-02-23+10,80024,298 total
  • Award

    Stock Option (Right to Buy)

    2022-02-23+18,60018,600 total
    Exercise: $11.75Exp: 2032-02-23Common Stock (18,600 underlying)
Footnotes (2)
  • [F1]These restricted stock units will vest in four equal annual installments beginning on February 23, 2023, subject to the Reporting Person's continuous service through the applicable vesting dates.
  • [F2]The option vests 25% on February 23, 2023, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES